These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18779311)

  • 1. Estimating risk from copper excess in human populations.
    Uauy R; Maass A; Araya M
    Am J Clin Nutr; 2008 Sep; 88(3):867S-71S. PubMed ID: 18779311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper deficiency and excess in infancy: developing a research agenda.
    Araya M; Koletzko B; Uauy R
    J Pediatr Gastroenterol Nutr; 2003 Oct; 37(4):422-9. PubMed ID: 14508211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-benefit analysis of mineral intakes: case studies on copper and iron.
    Fairweather-Tait SJ; Harvey LJ; Collings R
    Proc Nutr Soc; 2011 Feb; 70(1):1-9. PubMed ID: 20860861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of copper in light of new insights of copper homeostasis.
    de Romaña DL; Olivares M; Uauy R; Araya M
    J Trace Elem Med Biol; 2011 Jan; 25(1):3-13. PubMed ID: 21342755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory frameworks for copper considering chronic exposures of the population.
    Cockell KA; Bertinato J; L'Abbé MR
    Am J Clin Nutr; 2008 Sep; 88(3):863S-6S. PubMed ID: 18779310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological investigation on chronic copper toxicity to children exposed via the public drinking water supply.
    Zietz BP; Dieter HH; Lakomek M; Schneider H; Kessler-Gaedtke B; Dunkelberg H
    Sci Total Environ; 2003 Jan; 302(1-3):127-44. PubMed ID: 12526904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks of copper and iron toxicity during aging in humans.
    Brewer GJ
    Chem Res Toxicol; 2010 Feb; 23(2):319-26. PubMed ID: 19968254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of human exposure to copper: a case study using the NHEXAS database.
    Georgopoulos PG; Wang SW; Georgopoulos IG; Yonone-Lioy MJ; Lioy PJ
    J Expo Sci Environ Epidemiol; 2006 Sep; 16(5):397-409. PubMed ID: 16249795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling U-Shaped Exposure-Response Relationships for Agents that Demonstrate Toxicity Due to Both Excess and Deficiency.
    Milton B; Farrell PJ; Birkett N; Krewski D
    Risk Anal; 2017 Feb; 37(2):265-279. PubMed ID: 27043736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary exposure to copper in the European Union and its assessment for EU regulatory risk assessment.
    Sadhra SS; Wheatley AD; Cross HJ
    Sci Total Environ; 2007 Mar; 374(2-3):223-34. PubMed ID: 17270248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exposure-response curve for copper excess and deficiency.
    Chambers A; Krewski D; Birkett N; Plunkett L; Hertzberg R; Danzeisen R; Aggett PJ; Starr TB; Baker S; Dourson M; Jones P; Keen CL; Meek B; Schoeny R; Slob W
    J Toxicol Environ Health B Crit Rev; 2010 Oct; 13(7-8):546-78. PubMed ID: 21170809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic poisoning by copper in tap water: II. Copper intoxications with predominantly systemic symptoms.
    Eife R; Weiss M; Müller-Höcker M; Lang T; Barros V; Sigmund B; Thanner F; Welling P; Lange H; Wolf W; Rodeck B; Kittel J; Schramel P; Reiter K
    Eur J Med Res; 1999 Jun; 4(6):224-8. PubMed ID: 10383876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers.
    Cheah DM; Deal YJ; Wright PF; Buck NE; Chow CW; Mercer JF; Allen KJ
    Biometals; 2007 Oct; 20(5):751-7. PubMed ID: 17136311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper toxicosis in an Australian child.
    Walker NI
    Eur J Med Res; 1999 Jun; 4(6):249-51. PubMed ID: 10383881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Present situation of biomarkers for copper status.
    Olivares M; Méndez MA; Astudillo PA; Pizarro F
    Am J Clin Nutr; 2008 Sep; 88(3):859S-62S. PubMed ID: 18779309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the metabolism of copper.
    Aggett PJ
    Eur J Med Res; 1999 Jun; 4(6):214-6. PubMed ID: 10383873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on copper and liver disease in the dog.
    Thornburg LP
    J Vet Diagn Invest; 2000 Mar; 12(2):101-10. PubMed ID: 10730937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical conditions altering copper metabolism in humans.
    Beshgetoor D; Hambidge M
    Am J Clin Nutr; 1998 May; 67(5 Suppl):1017S-1021S. PubMed ID: 9587145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.